 Patricia Crew
Concepts (119)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myelin Proteolipid Protein | 14 | 2019 | 21 | 3.140 |
Why?
| | Introns | 7 | 2017 | 49 | 1.150 |
Why?
| | Oligodendroglia | 9 | 2021 | 34 | 1.080 |
Why?
| | Enhancer Elements, Genetic | 6 | 2019 | 64 | 0.940 |
Why?
| | Mice, Transgenic | 6 | 2019 | 656 | 0.560 |
Why?
| | Lac Operon | 5 | 2019 | 19 | 0.540 |
Why?
| | Central Nervous System | 3 | 2019 | 85 | 0.510 |
Why?
| | Peripheral Nervous System | 2 | 2019 | 18 | 0.510 |
Why?
| | Transgenes | 3 | 2019 | 55 | 0.480 |
Why?
| | Promoter Regions, Genetic | 4 | 2018 | 520 | 0.400 |
Why?
| | Transfection | 8 | 2018 | 399 | 0.360 |
Why?
| | Hippocampus | 1 | 2021 | 242 | 0.350 |
Why?
| | Brain | 3 | 2018 | 1387 | 0.340 |
Why?
| | Animals | 17 | 2021 | 14384 | 0.340 |
Why?
| | Ethanol | 1 | 2021 | 322 | 0.330 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 68 | 0.320 |
Why?
| | Mice | 13 | 2021 | 6413 | 0.310 |
Why?
| | Nervous System Diseases | 2 | 2019 | 97 | 0.300 |
Why?
| | Models, Theoretical | 1 | 2018 | 184 | 0.300 |
Why?
| | Sequence Deletion | 3 | 2012 | 99 | 0.290 |
Why?
| | Gene Expression Regulation | 4 | 2014 | 1062 | 0.290 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2012 | 151 | 0.260 |
Why?
| | DNA, Recombinant | 1 | 2015 | 17 | 0.260 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2015 | 8 | 0.260 |
Why?
| | Malate Dehydrogenase | 1 | 2014 | 11 | 0.260 |
Why?
| | Cell Line, Transformed | 5 | 2015 | 88 | 0.260 |
Why?
| | Lipogenesis | 1 | 2014 | 34 | 0.250 |
Why?
| | Exons | 1 | 2015 | 105 | 0.250 |
Why?
| | Cytosol | 1 | 2014 | 101 | 0.250 |
Why?
| | Nerve Tissue Proteins | 2 | 2006 | 199 | 0.250 |
Why?
| | Gastrointestinal Tract | 1 | 2014 | 135 | 0.230 |
Why?
| | Intestines | 1 | 2014 | 204 | 0.220 |
Why?
| | Intestinal Mucosa | 1 | 2014 | 259 | 0.220 |
Why?
| | Myelin Sheath | 2 | 2018 | 28 | 0.220 |
Why?
| | Down-Regulation | 2 | 2011 | 388 | 0.220 |
Why?
| | YY1 Transcription Factor | 1 | 2011 | 7 | 0.210 |
Why?
| | Myelin Basic Protein | 1 | 2011 | 6 | 0.200 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2011 | 29 | 0.200 |
Why?
| | Liver | 3 | 2014 | 1225 | 0.200 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 1999 | 0.190 |
Why?
| | Cell Proliferation | 1 | 2014 | 1096 | 0.190 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 2009 | 41 | 0.180 |
Why?
| | Chromosomes, Human, X | 1 | 2019 | 21 | 0.180 |
Why?
| | Quantitative Trait, Heritable | 1 | 2019 | 30 | 0.180 |
Why?
| | Leydig Cells | 1 | 2009 | 3 | 0.170 |
Why?
| | Genetic Association Studies | 1 | 2019 | 136 | 0.170 |
Why?
| | Chromosome Deletion | 1 | 2019 | 150 | 0.170 |
Why?
| | Nuclear Proteins | 2 | 2008 | 252 | 0.160 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 570 | 0.140 |
Why?
| | Proteomics | 1 | 2008 | 343 | 0.130 |
Why?
| | Transcription Factor AP-1 | 1 | 2004 | 64 | 0.120 |
Why?
| | Electrophoretic Mobility Shift Assay | 3 | 2011 | 74 | 0.110 |
Why?
| | DNA | 1 | 2005 | 581 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2021 | 1639 | 0.100 |
Why?
| | Neurogenesis | 1 | 2021 | 30 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 673 | 0.090 |
Why?
| | Microglia | 1 | 2021 | 137 | 0.090 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 46 | 0.080 |
Why?
| | Luminescent Proteins | 1 | 2018 | 66 | 0.080 |
Why?
| | Patch-Clamp Techniques | 1 | 2018 | 148 | 0.080 |
Why?
| | Cell Line | 3 | 2009 | 1153 | 0.080 |
Why?
| | Protein Isoforms | 2 | 2011 | 124 | 0.080 |
Why?
| | Protein Binding | 2 | 2011 | 736 | 0.080 |
Why?
| | Male | 6 | 2019 | 27311 | 0.080 |
Why?
| | Astrocytes | 1 | 2018 | 142 | 0.070 |
Why?
| | Blotting, Western | 2 | 2009 | 683 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 2 | 2009 | 206 | 0.070 |
Why?
| | Humans | 6 | 2019 | 54205 | 0.070 |
Why?
| | Transcription, Genetic | 2 | 2009 | 418 | 0.060 |
Why?
| | Immunoenzyme Techniques | 1 | 2014 | 165 | 0.060 |
Why?
| | Neurons | 1 | 2018 | 486 | 0.060 |
Why?
| | Genes, Reporter | 2 | 2005 | 98 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 206 | 0.060 |
Why?
| | Rats | 2 | 2014 | 3415 | 0.060 |
Why?
| | DNA Footprinting | 2 | 2004 | 13 | 0.060 |
Why?
| | Lipid Metabolism | 1 | 2014 | 194 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2015 | 634 | 0.060 |
Why?
| | Adiposity | 1 | 2014 | 142 | 0.060 |
Why?
| | Cuprizone | 1 | 2012 | 2 | 0.060 |
Why?
| | Monoamine Oxidase Inhibitors | 1 | 2012 | 8 | 0.060 |
Why?
| | Demyelinating Diseases | 1 | 2012 | 7 | 0.060 |
Why?
| | Base Sequence | 2 | 2004 | 719 | 0.060 |
Why?
| | Diet, High-Fat | 1 | 2014 | 216 | 0.050 |
Why?
| | Insulin Resistance | 1 | 2014 | 300 | 0.050 |
Why?
| | 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase | 1 | 2011 | 1 | 0.050 |
Why?
| | Animals, Newborn | 1 | 2012 | 396 | 0.050 |
Why?
| | Female | 4 | 2019 | 28410 | 0.050 |
Why?
| | Cell Lineage | 1 | 2011 | 93 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2014 | 1202 | 0.050 |
Why?
| | Cells, Cultured | 1 | 2014 | 1737 | 0.050 |
Why?
| | X Chromosome Inactivation | 1 | 2019 | 4 | 0.050 |
Why?
| | Chromosome Breakpoints | 1 | 2019 | 7 | 0.050 |
Why?
| | Comparative Genomic Hybridization | 1 | 2019 | 50 | 0.040 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2019 | 92 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 206 | 0.040 |
Why?
| | Pedigree | 1 | 2019 | 146 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2019 | 175 | 0.040 |
Why?
| | Age Factors | 1 | 2012 | 1198 | 0.040 |
Why?
| | Syndrome | 1 | 2019 | 252 | 0.040 |
Why?
| | Alternative Splicing | 1 | 2009 | 64 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2011 | 720 | 0.040 |
Why?
| | Mice, Jimpy | 1 | 2006 | 1 | 0.040 |
Why?
| | Schwann Cells | 1 | 2006 | 14 | 0.040 |
Why?
| | beta-Galactosidase | 1 | 2006 | 42 | 0.040 |
Why?
| | Sex Factors | 1 | 2019 | 766 | 0.040 |
Why?
| | Phenotype | 1 | 2019 | 820 | 0.040 |
Why?
| | 5' Flanking Region | 1 | 2005 | 6 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2005 | 59 | 0.030 |
Why?
| | Sus scrofa | 1 | 2005 | 39 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2005 | 57 | 0.030 |
Why?
| | Cattle | 1 | 2005 | 224 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2004 | 146 | 0.030 |
Why?
| | Binding Sites | 1 | 2004 | 440 | 0.030 |
Why?
| | 5' Untranslated Regions | 1 | 2002 | 33 | 0.030 |
Why?
| | Binding, Competitive | 1 | 2002 | 113 | 0.030 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 980 | 0.030 |
Why?
| | Organ Specificity | 1 | 2002 | 126 | 0.030 |
Why?
| | Child, Preschool | 1 | 2019 | 4146 | 0.020 |
Why?
| | Child | 1 | 2019 | 7340 | 0.020 |
Why?
|
|
Crew's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|